Bayesian Capital Management, LP - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2016$6,000
-85.0%
16,200
-78.7%
0.00%
-89.5%
Q1 2016$40,00076,1000.04%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 10,698,618$13,159,00015.42%
BVF INC/IL 43,795,613$53,869,0009.18%
DAFNA Capital Management LLC 3,195,381$3,930,0003.50%
Sio Capital Management, LLC 5,292,262$6,509,0002.88%
NEXTHERA CAPITAL LP 656,000$807,0001.14%
Lombard Odier Asset Management (USA) Corp 1,357,456$1,670,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,236,832$2,751,0000.11%
Consonance Capital Management LP 510,000$635,0000.08%
Candriam S.C.A. 1,515,000$1,863,0000.05%
SABBY MANAGEMENT, LLC 575,669$708,0000.04%
View complete list of CTI BIOPHARMA CORP shareholders